Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000503676 | SCV000594874 | likely benign | not specified | 2015-11-23 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000503676 | SCV000862528 | likely benign | not specified | 2018-07-19 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000905469 | SCV001050054 | benign | Insulin-dependent diabetes mellitus secretory diarrhea syndrome | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Clinical Genomics, |
RCV000905469 | SCV002605325 | benign | Insulin-dependent diabetes mellitus secretory diarrhea syndrome | criteria provided, single submitter | research | Potent mutations in FOXP3 gene are associated with a rare X linked condition called IPEX. It presents with immune dysregulation, secretory diarrhea, polyendocrinopathy which includes diabtes type 1, thyroiditis, growth hormone deficiency and hypoadrenalism. It is associated with pancreatic beta cell destruction.However no sufficient evidence is found to ascertain the role of this particular variant rs111856931, yet. | |
Prevention |
RCV003960166 | SCV004771009 | likely benign | FOXP3-related disorder | 2021-10-29 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |